Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas

Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas

Item

http://www.wikidata.org/entity/Q28268815

Q28268815

about

Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium Nuclear translocation of β-catenin during mesenchymal stem cells differentiation into hepatocytes is associated with a tumoral phenotype Cross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic Implications Integrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old Cdk1, Plks, Auroras, and Neks: the mitotic bodyguards Proteomic Analysis of Liver Proteins in a Rat Model of Chronic Restraint Stress-Induced Depression PLK1 blockade enhances therapeutic effects of radiation by inducing cell cycle arrest at the mitotic phase.Elevated levels of the polo kinase Cdc5 override the Mec1/ATR checkpoint in budding yeast by acting at different steps of the signaling pathway.Targeted depletion of Polo-like kinase (Plk) 1 through lentiviral shRNA or a small-molecule inhibitor causes mitotic catastrophe and induction of apoptosis in human melanoma cells.The RNA helicase/transcriptional co-regulator, p68 (DDX5), stimulates expression of oncogenic protein kinase, Polo-like kinase-1 (PLK1), and is associated with elevated PLK1 levels in human breast cancers Towards Prognostic Profiling of Non-Small Cell Lung Cancer: New Perspectives on the Relevance of Polo-Like Kinase 1 Expression, the TP53 Mutation Status and Hypoxia Proteomics for the discovery of nuclear bile acid receptor FXR targets Differential gene expression profile of retinoblastoma compared to normal retina Polo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidy Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways Full-Length Enrich c-DNA Libraries-Clear Cell-Renal Cell Carcinoma Replication of a genome-wide case-control study of esophageal squamous cell carcinoma.RASSF1A methylation indicates a poor prognosis in hepatoblastoma patients.Metastasis-associated gene, mag-1 improves tumour microenvironmental adaptation and potentiates tumour metastasis.Ruptured hepatoblastoma with massive internal bleeding in an adult iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors A case of hepatoblastoma misdiagnosed as combined hepatocellular carcinoma and cholangiocarcinoma in an adult.Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53 mutation and poor clinical outcom A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer Up-Regulation of Long Non-Coding RNA AB073614 Predicts a Poor Prognosis in Patients with Glioma.Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer.Inhibition of polo-like kinase 1 in glioblastoma multiforme induces mitotic catastrophe and enhances radiosensitisation Clinical prognostic value of DNA methylation in hepatoblastoma: Four novel tumor suppressor candidates.Overexpression of polo-like kinase1 predicts a poor prognosis in hepatocellular carcinoma patients.Modulating polo-like kinase 1 as a means for cancer chemoprevention Current issues and controversies in the classification of pediatric hepatocellular tumors.Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice.Gene expression profiling of human hepatoblastoma using archived formalin-fixed and paraffin-embedded tissues.The clinical and prognostic value of polo-like kinase 1 in lung squamous cell carcinoma patients: immunohistochemical analysis.OASIS modulates hypoxia pathway activity to regulate bone angiogenesis.Spotlight on Volasertib: Preclinical and Clinical Evaluation of a Promising Plk1 Inhibitor.Suppression of interferon β gene transcription by inhibitors of bromodomain and extra-terminal (BET) family members A Brief Report of Immunohistochemical Markers to Identify Aggressive Hepatoblastoma.Plk1-mediated phosphorylation of UAP56 regulates the stability of UAP56.Polo-like kinase 1 expression is a prognostic factor in human colon cancer.

P2860

Q26828479-61DF21B4-95F0-44FB-B57D-58417C73A2F9 Q27305074-2A74B429-7DE2-4D8B-A504-1ABC9B2E70E1 Q28076060-EA667C94-B0E7-4829-A019-B34A691B26FF Q28396741-72718760-232C-4BA6-9560-F6040997E8BC Q28611400-2DCC64A1-2719-4A88-8147-AEB344DFF3D3 Q29248185-B2AE7DE4-92F0-4A7D-B90D-24651F208BF0 Q30670722-4445E128-15B0-4997-8BA5-8850E8CE9A9E Q33526233-9EAD801D-590A-4A14-8774-2C8D44D10DAD Q33564389-93D51AB4-27A6-4B91-BEDB-990CE04BBB82 Q33728889-2F58854E-379C-4C2C-B4A2-2ACF07DB7000 Q33820876-3210F2F1-0C85-4201-AC2D-E1C918066E9B Q33856588-84B6CF52-B6D1-4B97-AA74-F8908D6D6E25 Q33994376-83071DB8-A20B-46A9-8C76-4FAAA7714EC1 Q34144573-307E600C-0F01-419E-B5B0-7366BB2FDFBE Q34212362-F7BA8EDD-29F6-4333-8622-2258983664AD Q34250998-0DE74F74-8330-4EDB-8079-1CEE10DE06BD Q34799701-B4999AC4-8C94-45BA-AF53-8F595FAE465E Q34976827-90ECC321-A88D-4299-9716-D262A5721FB2 Q35370402-C3D68491-8D02-4449-85EC-E5E3E4A3BD83 Q35621384-4BE42706-F7DE-4EFB-A81D-AB14832FA966 Q35754900-9345BC50-C6D1-4013-944C-A74E0AC5522E Q36181211-E6760A88-E34C-46A5-B51A-7F07EAF107EE Q36245509-EF3C8904-F508-40C9-BCD7-826327029701 Q36413189-0E3AE58B-19E5-4D95-ABE1-054E55EFD2C7 Q36841827-A43AD9B3-6EF9-477E-90C2-2A4E4C588385 Q37059611-FBE7EE6F-556A-44C7-B1F1-048D50CDAD2B Q37126130-19B595D6-6406-409B-8E11-00E24ABA38FF Q37142441-2060C556-0CB2-4916-9870-EF1B3ECA4C08 Q37335160-4D86B0D3-048C-4703-9BEB-920E0CD2E608 Q37682665-25FDC244-1E42-4864-B7AF-0D41869C569C Q38014789-7E9DB5F8-32F0-4732-A141-5AC566F7BA41 Q38294269-998CEDB1-558E-49C4-B20C-20406645D451 Q38411627-50D96686-4092-42F1-8B73-42E88B329643 Q38671515-FE85FBDC-C819-42D2-BD46-447D9FFE8241 Q38820244-0771B477-4C55-4DF6-ADC3-D25F17A47C9F Q38824242-867DFB9A-A52D-4987-814D-6EF871DD0B96 Q38884906-C75C12FA-2C6A-41F3-A2AD-ABB8F8B00C36 Q39130327-75AF81EB-76AB-4D6C-BA31-2540E50060A0 Q39531210-32846066-C4EE-43A8-B766-55C7FABC529C Q40359903-41145677-F03A-4FAC-BF68-EA17A4DB9248

P2860

Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas

Item

http://www.wikidata.org/entity/Q28268815

description

2004 nî lūn-bûn

@nan

2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu